ERBB2 and cancer: When stratifying breast cancer tissues into different molecular subtypes, we found that DLEU1 expression was significantly higher in triple-negative breast cancer (TNBC) tissues (n = 116) than in luminal (n = 566) or HER2-positive cancers (n = 37; Fig. 1E).